Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 10Sanofi
02 1Biocon
03 1Biocon Biologics
04 4Biosimilar Collaborations Ireland Limited
05 106Novo Nordisk
06 1ORIFARM GROUP AS
01 4CAT
02 1INJ
03 10INJECTABLE;SUBCUTANEOUS
04 3INJECTION;SOLUTION
05 9Injectable Solution
06 1Injectable Solution In Cartridge
07 3Injection
08 1Insulin Aspart 160U 1,6Ml 5 Units Parenteral Use
09 2Insulin Aspart 300Iu 3Ml 5 Units Parenteral Use
10 3PED
11 2PFP
12 9SOLUTION
13 1SOLUTION;INTRAVENOUS, SUBCUTANEOUS
14 3SOLUTION;SUBCUTANEOUS
15 2SUSPENSION
16 1Soluble Insulin Aspart+Insulin Aspart Crystallised Protamino 30/70 300Iu 3Ml 5 Units Parenteral Use
17 1Soluble Insulin Aspart+Insulin Aspart Crystallised Protamino 50/50 300Iu 3Ml 5 Units Parenteral Use
18 1Soluble Insulin Aspart+Insulin Aspart Crystallised Protamino 70/30 300Iu 3Ml 5 Units Parenteral Use
19 49Solution For Injection
20 13Suspension For Injection
21 4Blank
01 11Allowed
02 22Approved
03 6Deregistered
04 11Marketed
05 10Originator
06 20Prescription
07 11Schedule D
08 32Blank
01 4FIASP
02 1FIASP FLEXTOUCH
03 1FIASP PENFILL
04 12Fiasp
05 1Fiasp Eml ultra-fast-acting PumpCart
06 1Fiasp Penfill
07 1Fiasp Pumpcart
08 1Fiasp ultra-fast-acting
09 1Fiasp ultra-fast-acting FlexTouch
10 1Fiasp ultra-fast-acting Penfill
11 3Insulin Aspart Sanofi
12 1Insulin NovoNordisk NovoRapid
13 1Insulin NovoNordisk NovoRapid FlexPen
14 1Insulin NovoNordisk NovoRapid FlexTouch
15 1Insulin NovoNordisk NovoRapid Penfill
16 1Insulin NovoNordisk NovoRapid PumpCart Eml
17 2KIRSTY
18 4Kirsty
19 1MERILOG
20 1MERILOG SOLOSTAR
21 1NOVOLOG
22 1NOVOLOG FLEXPEN
23 1NOVOLOG FLEXTOUCH
24 1NOVOLOG INNOLET
25 1NOVOLOG MIX 50/50
26 1NOVOLOG MIX 70/30
27 1NOVOLOG MIX 70/30 FLEXPEN
28 2NOVOLOG MIX 70/30 PENFILL
29 1NOVOLOG PENFILL
30 2NOVOMIX 30
31 2NOVORAPID
32 2NovoMix 30
33 1NovoMix 30 FlexPen
34 1NovoMix 30 Penfill 3 mL
35 5NovoRapid
36 1NovoRapid FlexPen
37 2NovoRapid Flexpen
38 1NovoRapid Penfill
39 1NovoRapid Penfill 3 mL
40 1NovoRapid PumpCart
41 1NovoRapid® FlexPen®
42 1NovoRapid® Penfill®
43 3Novomix
44 2Novomix 30 Flexpen
45 1Novomix 30 Flexpen 100 U/ml
46 1Novomix 30 Novolet
47 2Novomix 30 Penfill
48 1Novomix 30 Penfill 100 U/ml
49 2Novomix 50 Flexpen
50 2Novomix 50 Penfill
51 2Novomix 70 Flexpen
52 2Novomix 70 Penfill
53 3Novorapid
54 3Novorapid Flexpen
55 2Novorapid Flextouch
56 2Novorapid Innolet
57 1Novorapid Novolet
58 2Novorapid Penfill
59 2Novorapid Pumpcart
60 1Novorapidfill
61 1RYZODEG 70/30
62 1Ryzodeg 100 Ãœhikut/Ml Flexpen
63 1Ryzodeg 100 Ãœhikut/Ml Flextouch
64 1Ryzodeg 100 Ãœhikut/Ml Penfill
65 1Ryzodeg FlexTouch
66 1Ryzodeg Flexpen
67 1Ryzodeg Flextouch
68 3Ryzodeg Penfill
69 3Ryzodeg®
70 3TRURAPI
71 2Truvelog Mix 30
01 7Australia
02 11Canada
03 20Estonia
04 6Italy
05 2Moldova
06 11Norway
07 10South Africa
08 28Sweden
09 11Switzerland
10 17USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : USA
Brand Name : MERILOG
Dosage Form : INJECTION;SOLUTION
Dosage Strength : 10ML(100UNITS/ML)
Packaging :
Approval Date :
Application Number : 761325
Regulatory Info :
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : USA
Brand Name : MERILOG SOLOSTAR
Dosage Form : INJECTION;SOLUTION
Dosage Strength : 3ML(100UNITS/ML)
Packaging :
Approval Date :
Application Number : 761325
Regulatory Info :
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Insulin Aspart Sanofi
Dosage Form : Injectable Solution
Dosage Strength : 100E/ml
Packaging :
Approval Date : 21/04/2021
Application Number : 20200727000046
Regulatory Info : Approved
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Insulin Aspart Sanofi
Dosage Form : Solution For Injection
Dosage Strength : 100E/ml
Packaging :
Approval Date : 25/06/2020
Application Number : 20190604000057
Regulatory Info : Approved
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Insulin Aspart Sanofi
Dosage Form : Solution For Injection
Dosage Strength : 100E/ml
Packaging :
Approval Date : 25/06/2020
Application Number : 20190604000064
Regulatory Info : Approved
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Deregistered
Registration Country : Sweden
Insulin Aspart (Soluble); Insulin Aspart Protamine
Brand Name : Truvelog Mix 30
Dosage Form : Suspension For Injection
Dosage Strength : 100E/ml
Packaging :
Approval Date : 25/04/2022
Application Number : 20210429000121
Regulatory Info : Deregistered
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Deregistered
Registration Country : Sweden
Insulin Aspart (Soluble); Insulin Aspart Protamine
Brand Name : Truvelog Mix 30
Dosage Form : Injectable Solution
Dosage Strength : 100E/ml
Packaging :
Approval Date : 25/04/2022
Application Number : 20210429000114
Regulatory Info : Deregistered
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : TRURAPI
Dosage Form : SOLUTION
Dosage Strength : 100UNIT/ML
Packaging :
Approval Date :
Application Number : 2506564
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : TRURAPI
Dosage Form : SOLUTION
Dosage Strength : 100UNIT/ML
Packaging :
Approval Date :
Application Number : 2506572
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : TRURAPI
Dosage Form : SOLUTION
Dosage Strength : 100UNIT/ML
Packaging :
Approval Date :
Application Number : 2529254
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info :
Registration Country : USA
Brand Name : NOVOLOG
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 1000 UNITS/10ML (100 UNITS/ML)
Packaging :
Approval Date :
Application Number : 20986
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NOVOLOG PENFILL
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)
Packaging :
Approval Date :
Application Number : 20986
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NOVOLOG FLEXPEN
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)
Packaging :
Approval Date :
Application Number : 20986
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NOVOLOG INNOLET
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)
Packaging :
Approval Date :
Application Number : 20986
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NOVOLOG FLEXTOUCH
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)
Packaging :
Approval Date :
Application Number : 20986
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
Brand Name : NOVOLOG MIX 70/30
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 700 UNITS/10ML; 300 UNITS/10ML (70 UNITS/ML; 30 UNITS/ML)
Packaging :
Approval Date :
Application Number : 21172
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
Brand Name : NOVOLOG MIX 70/30 PENFILL
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 210 UNITS/3ML;90 UNITS/3ML (70 UNITS/ML; 30 UNITS/ML)
Packaging :
Approval Date :
Application Number : 21172
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
Brand Name : NOVOLOG MIX 70/30 PENFILL
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 210 UNITS/3ML;90 UNITS/3ML (70 UNITS/ML; 30 UNITS/ML)
Packaging :
Approval Date :
Application Number : 21172
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
Brand Name : NOVOLOG MIX 70/30 FLEXPEN
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 210 UNITS/3ML; 90 UNITS/3ML (70 UNITS/ML; 30 UNITS/ML)
Packaging :
Approval Date :
Application Number : 21172
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
Brand Name : NOVOLOG MIX 50/50
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 50 UNITS/ML;50 UNITS/ML
Packaging :
Approval Date :
Application Number : 21810
Regulatory Info :
Registration Country : USA
